External quality assessment results of in vitro analysis of nuclear medicine from 2004 to 2018 in Shanghai
	    		
		   		
		   			 
		   		
	    	
    	 
    	10.3760/cma.j.cn321828-20210111-00004
   		
        
        	
        		- VernacularTitle:2004至2018年上海市核医学体外分析室间质评结果分析
- Author:
	        		
		        		
		        		
			        		Xin SHI
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Keqing SHI
			        		
			        		;
		        		
		        		
		        		
			        		Jinming ZHANG
			        		
			        		;
		        		
		        		
		        		
			        		Xingdang LIU
			        		
			        		
		        		
		        		
		        		
    Author Information Author Information
 
			        		
			        		
			        			1. 复旦大学附属华山医院核医学科、上海市核医学质量控制中心 200040
 
 
- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Clinical laboratory techniques;
			        		
			        		
			        		
				        		Quality control;
			        		
			        		
			        		
				        		Nuclear medicine;
			        		
			        		
			        		
				        		Shanghai
			        		
			        		
	        			
        			
        		
- From:
	            		
	            			Chinese Journal of Nuclear Medicine and Molecular Imaging
	            		
	            		 2022;42(8):487-490
	            	
            	
- CountryChina
- Language:Chinese
- 
		        	Abstract:
			       	
			       		
				        
				        	Objective:To analyze the results of external quality assessment (EQA) of Shanghai Nuclear Medicine Quality Control Center, in order to further strengthen the quality control and management of in vitro testing laboratories. Methods:The EQA results of 41 units evaluated by Shanghai Nuclear Medicine Quality Control Center from 2004 to 2018 were summarized and retrospectively analyzed. The overall qualified rate of all items (total triiodothyronine, TT 3; total thyroxine, TT 4; free triiodothyronine, FT 3; free thyroxine, FT 4; thyroid stimulating hormone, TSH; alpha fetoprotein, AFP; carcinoembryonic antigen, CEA; total prostate specific antigen, TPSA) and the qualified rate of singe item over the years were calculated respectively. Results:From 2004 to 2018, the overall qualified rates of all items of the laboratories were 84.0%(356/424), 90.1%(381/423), 94.8%(399/421), 94.8%(291/307), 96.6%(308/319), 97.2%(280/288), 96.6%(224/232), 97.8%(225/230), 98.7%(224/227), 100.0%(221/221), 99.5%(218/219), 98.6%(215/218), 99.5%(217/218), 99.5%(189/190), 100.0%(90/90), respectively; and the qualified rate of singe item showed an upward trend, but there were still some laboratories′ EAQ results did not reach " qualified" , and there may be potential risk factors affecting the test results during the test process.Conclusions:The qualified rates of in vitro testing laboratories evaluated by Shanghai Nuclear Medicine Quality Control Center show an upward trend from 2004 to 2018. Analyzing the EQA results can help to find the potential risks in the laboratory and improve the detection ability.